Emerald Mutual Fund Advisers Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-129,878	Closed	-$8.62M	–	304
2019 Q3	$8.62M	Sell	129,878 -8,020	-6%	-$539K	0.38%	99
2019 Q2	$11M	Buy	137,898 +27,080	+24%	+$2.42M	0.44%	81
2019 Q1	$12.4M	Buy	+110,818	New	+$12.1M	0.5%	68
2018 Q1	–	Sell	-115,679	Closed	-$6.76M	–	262
2017 Q4	$6.76M	Buy	+115,679	New	+$7.29M	0.27%	128
2017 Q1	–	Sell	-65,654	Closed	-$7.13M	–	293
2016 Q4	$7.13M	Buy	65,654 +2,421	+4%	+$288K	0.34%	107
2016 Q3	$10.4M	Buy	63,233 +21,742	+52%	+$3.43M	0.53%	77
2016 Q2	$5.92M	Buy	41,491 +24,021	+137%	+$3.5M	0.33%	109
2016 Q1	$2.24M	Sell	17,470 -8,930	-34%	-$1.05M	0.13%	156
2015 Q4	$3.94M	Sell	26,400 -19,420	-42%	-$3.29M	0.21%	135
2015 Q3	$7.6M	Buy	45,820 +11,456	+33%	+$2.52M	0.5%	77
2015 Q2	$8.29M	Sell	34,364 -4,435	-11%	-$1.18M	0.64%	62
2015 Q1	$10.4M	Sell	38,799 -1,428	-4%	-$309K	0.85%	45
2014 Q4	$6.28M	Buy	+40,227	New	+$7.43M	0.54%	69
2014 Q3	–	Sell	-16,248	Closed	-$3.85M	–	236
2014 Q2	$3.85M	Sell	16,248 -10,573	-39%	-$2.79M	0.35%	98
2014 Q1	$8.85M	Sell	26,821 -73,896	-73%	-$24.9M	0.85%	42
2013 Q4	$11.4M	Buy	100,717 +10,136	+11%	+$586K	0.68%	55
2013 Q3	$6.25M	Buy	90,581 +67,105	+286%	+$3.31M	0.86%	41
2013 Q2	$1.05M	Buy	+23,476	New	+$802K	0.18%	125

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's ICPT Position: Q4 2019 in Review

Emerald Mutual Fund Advisers Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 129,878 shares — an estimated $8.62M sold.

Emerald Mutual Fund Advisers Trust first reported a position in ICPT in Q2 2013 and held it in 18 quarters. The position peaked at $12.4M in Q1 2019. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

Emerald Mutual Fund Advisers Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 129,878 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $8.62M.
Emerald Mutual Fund Advisers Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
Emerald Mutual Fund Advisers Trust's Intercept Pharmaceuticals, Inc. position peaked at $12.4M in Q1 2019.
215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.